Engineering modular intracellular protein sensor-actuator devices

Understanding and reshaping cellular behaviors with synthetic gene networks requires the ability to sense and respond to changes in the intracellular environment. Intracellular proteins are involved in almost all cellular processes, and thus can provide important information about changes in cellular conditions such as infections, mutations, or disease states. Here we report the design of a modular platform for intrabody-based protein sensing-actuation devices with transcriptional output triggered by detection of intracellular proteins in mammalian cells. We demonstrate reporter activation response (fluorescence, apoptotic gene) to proteins involved in hepatitis C virus (HCV) infection, human immunodeficiency virus (HIV) infection, and Huntington’s disease, and show sensor-based interference with HIV-1 downregulation of HLA-I in infected T cells. Our method provides a means to link varying cellular conditions with robust control of cellular behavior for scientific and therapeutic applications.Synthetic biology principles are often used to design circuits that tune gene expression in response to changes in intracellular environments. Here the authors design a modular platform for intracellular protein sensing devices with transcriptional output.

[1]  Martin Fussenegger,et al.  Vitamin H-regulated transgene expression in mammalian cells , 2007, Nucleic acids research.

[2]  Y. Berdichevsky,et al.  HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen. , 2005, Journal of molecular biology.

[3]  J. Stelling,et al.  A tunable synthetic mammalian oscillator , 2009, Nature.

[4]  W. Marasco,et al.  Intracellular antibodies (intrabodies) and their therapeutic potential. , 2008, Handbook of experimental pharmacology.

[5]  Jacob Beal,et al.  Model-driven engineering of gene expression from RNA replicons. , 2015, ACS synthetic biology.

[6]  Summer B. Thyme,et al.  Redesigning the specificity of protein-DNA interactions with Rosetta. , 2014, Methods in molecular biology.

[7]  A. Ali,et al.  scFv Antibody: Principles and Clinical Application , 2012, Clinical & developmental immunology.

[8]  C. Hammers,et al.  Antibody phage display: technique and applications. , 2014, The Journal of investigative dermatology.

[9]  Joshua N Leonard,et al.  Rewiring human cellular input-output using modular extracellular sensors. , 2017, Nature chemical biology.

[10]  Nayoung Kim,et al.  Tat-Induced FOXO3a Is a Key Mediator of Apoptosis in HIV-1-Infected Human CD4+ T Lymphocytes1 , 2008, The Journal of Immunology.

[11]  A. Fauci,et al.  The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 , 2013, PLoS pathogens.

[12]  S. Arold,et al.  The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. , 1997, Structure.

[13]  Martin Fussenegger,et al.  A general design strategy for protein-responsive riboswitches in mammalian cells , 2014, Nature Methods.

[14]  Susan Engelbrecht,et al.  Functions of Tat: the versatile protein of human immunodeficiency virus type 1. , 2010, The Journal of general virology.

[15]  D. di Bernardo,et al.  miRNAs confer phenotypic robustness to gene networks by suppressing biological noise , 2013, Nature Communications.

[16]  I. Arisi,et al.  Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies , 2017, Nature Methods.

[17]  S. Bartz,et al.  Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 , 1999, Journal of Virology.

[18]  S. Benichou,et al.  Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody. , 2011, Blood.

[19]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Serge Muyldermans,et al.  Nanobodies as Probes for Protein Dynamics in Vitro and in Cells* , 2015, The Journal of Biological Chemistry.

[21]  D. Trono,et al.  The Nef protein of primate lentiviruses , 1999, Reviews in Medical Virology.

[22]  S. Basmaciogullari,et al.  The activity of Nef on HIV-1 infectivity , 2014, Front. Microbiol..

[23]  A. McMichael,et al.  Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. , 2001, Immunity.

[24]  W. Marasco,et al.  Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. , 1999, Journal of immunological methods.

[25]  R. Weiss,et al.  CRISPR transcriptional repression devices and layered circuits in mammalian cells , 2014, Nature Methods.

[26]  T. Copeland,et al.  The P1' specificity of tobacco etch virus protease. , 2002, Biochemical and biophysical research communications.

[27]  N. Wittenburg,et al.  Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. , 1999, Nucleic acids research.

[28]  Rosemary M. McCloskey,et al.  Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes , 2013, Retrovirology.

[29]  Shinya Yamanaka,et al.  Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. , 2015, Cell stem cell.

[30]  Christina D Smolke,et al.  Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins , 2010, Science.

[31]  Yvonne Y Chen,et al.  T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells , 2016, Cancer Immunology Research.

[32]  G. Barnea,et al.  The genetic design of signaling cascades to record receptor activation , 2008, Proceedings of the National Academy of Sciences.

[33]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[34]  P. Patterson,et al.  Intrabodies Binding the Proline-Rich Domains of Mutant Huntingtin Increase Its Turnover and Reduce Neurotoxicity , 2008, The Journal of Neuroscience.

[35]  V. Sasseville,et al.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.

[36]  C. Rice,et al.  Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines , 2000, Journal of Virology.

[37]  Jacob Beal,et al.  A Method for Fast, High-Precision Characterization of Synthetic Biology Devices , 2012 .

[38]  C. Ross,et al.  Huntington's disease: from molecular pathogenesis to clinical treatment , 2011, The Lancet Neurology.

[39]  Markus Wieland,et al.  Engineered UV-A light-responsive gene expression system for measuring sun cream efficacy in mammalian cell culture. , 2014, Journal of biotechnology.

[40]  Yuntao Wu,et al.  Selective Transcription and Modulation of Resting T Cell Activity by Preintegrated HIV DNA , 2001, Science.

[41]  Martin Fussenegger,et al.  Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome , 2012, Proceedings of the National Academy of Sciences.

[42]  Gerard D. Wright,et al.  Opportunities for Synthetic Biology in Antibiotics: Expanding Glycopeptide Chemical Diversity , 2012, ACS synthetic biology.